Central Venous Pressure Monitoring and Prognosis of High-risk Operating Patients
1 other identifier
observational
196
0 countries
N/A
Brief Summary
While central venous pressure measurement is used to guide fluid management in high risk surgical patients during perioperative period, the relationship between the value of central venous pressure and organ dysfunction and prognosis of high-risk operating patients is unknow. In this study, we conducted a retrospective study of the relationship between the initial levels of CVP with organ dysfunction, the severity of illness, the length of ICU stay, and prognosis of critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2014
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedFirst Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedOctober 22, 2020
October 1, 2020
4.2 years
October 15, 2020
October 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Outcome
28-day mortality, length of stay in intensive care unit and hospitalization, surgical complications
28-day
Secondary Outcomes (1)
Secondary Outcome
1-day
Study Arms (3)
Group A
Patients with the initial central venous pressure(CVP1) \<8 mm Hg
Group B
Patients with 8≤CVP1≤12mm Hg
Group C
Patients with CVP1\>12 mm Hg
Interventions
Because this study was a retrospective study, no intervention measures were implemented for the patients enrolled.
Eligibility Criteria
This is a single-center, retrospective, observational study enrolled 196 patients undergoing high-risk surgery who admitted to surgical intensive care unit(SICU) directly after operation from Feb 1,2014 to Mar 31,2018.
You may qualify if:
- Age ≥18 years.⑵ All patients undergoing surgery and admitted to our intensive care unit (ICU) directly after surgery were enrolled into the respective study.⑶ They stayed in the ICU more than 48 hours with central venous pressure monitored for more than 48 hours.
You may not qualify if:
- Patients who were in pregnancy. ⑵Older than 80 years. ⑶Underwent cardiac surgery or had chronic kidney disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiafang Wu, M.D.
Department of Critical Care Medicine, Fujian Provincial Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 28 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Critical Care Medicine, Fujian Provincial Hospital
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 22, 2020
Study Start
February 1, 2014
Primary Completion
March 31, 2018
Study Completion
March 30, 2020
Last Updated
October 22, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share